home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)

15.87 -0.38 (-2.34%)

Official Closing Price Updated: 7:00 PM EDT, May 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Friday the Thirteenth ↗

August 13, 2021

The stock week in points eastward was mixed. The USA markets face a bear correction.

Via Talk Markets

Takeda To Lead Finch-Partnered Microbiome IBD Drug ↗

August 10, 2021

Finch Therapeutics Group Inc (NASDAQ: FNCH) announced that Takeda Pharmaceutical Company Limited (NYSE: TAK) has elected to take the lead on the development of FIN...

Via Benzinga

Why BioCryst Pharmaceuticals Rose 8% on Thursday ↗

August 05, 2021

The company's first commercial drug launch keeps exceeding expectations.

Via The Motley Fool

Topics Earnings

Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks

August 05, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Analyzing Takeda Pharmaceutical's Unusual Options Activity ↗

August 03, 2021

Shares of Takeda Pharmaceutical (NYSE:TAK) saw some unusual ...

Via Benzinga

Understanding Takeda Pharmaceutical's Unusual Options Activity ↗

July 30, 2021

Takeda Pharmaceutical (NYSE:TAK) shares experienced unusual ...

Via Benzinga

Know When To Hold 'Em, Know When To Fold 'Em ... ↗

August 02, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

Via Talk Markets

Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie

August 01, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress

July 30, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Timeless Values, Life-Changing Progress

June 30, 2021

SOURCE: Takeda

Via 3BL Media

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate

July 29, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Full News Day ↗

July 28, 2021

The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.

Via Talk Markets

Topics Energy

Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag ↗

July 28, 2021

The FDA has granted Breakthrough Therapy Designation to Takeda Pharmaceutical Company Limited's (NYSE: TAK) TAK-994 for excessive daytime sleepiness (EDS...

Via Benzinga

U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1)

July 28, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

XBIO Stock: Xenetic Soars on Private Placement Announcement ↗

July 26, 2021

XBIO stock is continuing a heck of a week. Just days after it was boosted by Takeda's expansion news, it's looking at a big private sale.

Via InvestorPlace

Containment Plan ↗

July 23, 2021

Today the US decided to cut China risks.

Via Talk Markets

“Claw-Back” day ↗

July 20, 2021

The rally was just as irrational as the selloff.

Via Talk Markets

Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders

July 20, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Moderna Extends Rally With Expanded Japanese COVID-19 Vaccine Supply Deal ↗

July 20, 2021

Moderna, Inc. (NASDAQ: MRNA) shares appear to be going from strength to strength, and the premarket price action Tuesday suggests a positive open for the fifth straight...

Via Benzinga

Japan To Buy Additional 50M Doses Of Moderna COVID-19 Vaccine ↗

July 20, 2021

Moderna Inc (NASDAQ: MRNA) has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co Ltd (NYSE: TAK) will...

Via Benzinga

Takeda Announces the Submission of Its Corporate Governance Report to the Tokyo Stock Exchange

July 19, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Selloff Round 3 ↗

July 13, 2021

Stocks fell across the board in foreign countries, except for Britain which was upbeat.

Via Talk Markets

Recovery Friday ↗

July 09, 2021

The big winners this week were Financials.

Via Talk Markets

New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

July 10, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Sell Sell Sell ↗

July 06, 2021

Today the inevitable reversal of wild gains overtook Wall Street, echoing what occurred in major foreign markets Monday.

Via Talk Markets

Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates ↗

July 01, 2021

June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...

Via Benzinga

End Of June ↗

June 30, 2021

Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made.

Via Talk Markets

Topics Initial Public Offering

Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020

June 29, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus ↗

June 27, 2021

Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big...

Via Benzinga

Summer Friday ↗

June 25, 2021

The stock market tried for another record after yesterday's late blowout over the infrastructure deal.

Via Talk Markets

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com